About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in Chicago | 115 Studies

Clinical Trials COVID-19Chicago

COVID-19 Clinical Trials in Chicago

Find 115 clinical trials for covid-19 near Chicago, Illinois. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 115 trials

TerminatedA Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and AdultsThe primary objective of the study is to evaluate the effect of casirivimab+imdevimab, compared with placebo, in preventing symptomatic SARS-CoV-2 infection in immunocompromised…NCT05074433·Birmingham, Alabama and 66 others

COVID-19 Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedLow vs. Moderate to High Dose Vitamin D for Prevention of COVID-19The purpose of this study is to compare the risks of COVID-19 in individuals from Chicagoland communities randomized to low (400 IU/day) vs. moderate (4,000 IU/day) or high…NCT04868903·Chicago, Illinois and 1 other

CompletedA Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection.NCT04470427·Birmingham, Alabama and 99 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05894538·Gilbert, Arizona and 92 others

CompletedStudy of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced PneumoniaThis was a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of canakinumab plus standard-of-care (SOC) compared with placebo plus…NCT04362813·Birmingham, Alabama and 38 others

CompletedImproving Attention in Individuals With Long COVID-19This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid.NCT06503874·Chicago, Illinois

Active not recruitingAssessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID FibrosisThe primary purpose of this study is to determine whether the drug sirolimus reduces the likelihood of developing of pulmonary fibrosis in patients who are hospitalized with…NCT04948203·Chicago, Illinois

CompletedCOVID Protection After Transplant - Sanofi GSK (CPAT-SG) StudyAn open label, non-randomized pilot study in kidney transplant recipients who received a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have…NCT05518487·San Diego, California and 5 others

CompletedPassive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized AdultsThe purpose of this study is to test the safety and efficacy of convalescent donor plasma to treat COVID-19 in hospitalized adults in a randomized, placebo-controlled setting.NCT04362176·Little Rock, Arkansas and 25 others

CompletedCOVID-19: Human Epidemiology and Response to SARS-CoV-2The human disease caused by SARS-CoV-2 is called COVID-19. In most cases, COVID-19 presents as a mild to moderate respiratory illness.NCT04375761·Aurora, Colorado and 19 others

CompletedA Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19The purpose of this study is to evaluate the clinical response of sirukumab (administered as a single intravenous dose) plus standard of care (SOC) compared to placebo plus SOC in…NCT04380961·Long Beach, California and 15 others

CompletedRECOVER-SLEEP: Platform ProtocolThe platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types.NCT06404086·Phoenix, Arizona and 46 others

CompletedPhase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsThe aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.NCT04516746·Phoenix, Arizona and 83 others

CompletedA Study of mRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-1283.222 versus mRNA-1273.222…NCT05815498·Huntsville, Alabama and 229 others

CompletedA Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV-2) infection.NCT04649151·Banning, California and 52 others

CompletedCOVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 VaccinationsBackground: Allergic reactions have been reported to occur after vaccination with both the Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine.NCT04761822·Tucson, Arizona and 28 others

CompletedRetail COVID-19 StudyDespite the availability of vaccines, there remains a need to identify specific immune responses that correlate with protection against SARS-CoV-2 infection.NCT06761612·Kissimmee, Florida and 19 others

CompletedStudy to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).NCT04644120·Glendale, California and 17 others

UnknownNA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 InfectionThis Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechanical ventilation) with SARS…NCT04452565·Los Angeles, California and 30 others

TerminatedStudy of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and OlderThe purpose of this Phase III study is to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent) as part of primary series…NCT04904549·Birmingham, Alabama and 85 others

PreviousPage 2 of 6Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia